ID ALAT1_HUMAN Reviewed; 496 AA. AC P24298; B0YJ18; D3DWM7; P78398; Q93076; DT 01-MAR-1992, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 24-JAN-2024, entry version 214. DE RecName: Full=Alanine aminotransferase 1; DE Short=ALT1; DE EC=2.6.1.2; DE AltName: Full=Glutamate pyruvate transaminase 1; DE Short=GPT 1; DE AltName: Full=Glutamic--alanine transaminase 1; DE AltName: Full=Glutamic--pyruvic transaminase 1; GN Name=GPT; Synonyms=AAT1, GPT1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-14. RX PubMed=9119391; DOI=10.1006/geno.1996.4604; RA Sohocki M.M., Sullivan L.S., Harrison W.R., Sodergren E.J., Elder F.F.B., RA Weinstock G., Tanase S., Daiger S.P.; RT "Human glutamate pyruvate transaminase (GPT): localization to 8q24.3, cDNA RT and genomic sequences, and polymorphic sites."; RL Genomics 40:247-252(1997). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RG NHLBI resequencing and genotyping service (RS&G); RL Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-14. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PROTEIN SEQUENCE OF 2-496, CLEAVAGE OF INITIATOR METHIONINE, AND RP ACETYLATION AT ALA-2. RC TISSUE=Liver; RX PubMed=1931970; DOI=10.1021/bi00107a013; RA Ishiguro M., Takio K., Suzuki M., Oyama R., Matsuzawa T., Titani K.; RT "Complete amino acid sequence of human liver cytosolic alanine RT aminotransferase (GPT) determined by a combination of conventional and mass RT spectral methods."; RL Biochemistry 30:10451-10457(1991). RN [7] RP NUCLEOTIDE SEQUENCE [MRNA] OF 4-496. RC TISSUE=Liver; RA Funatsu M., Tanase S., Nakao J., Hamada F., Oka T., Morino Y.; RT "Human mRNA for alanine aminotransferase."; RL Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases. RN [8] RP TISSUE SPECIFICITY. RX PubMed=11863375; DOI=10.1006/geno.2002.6722; RA Yang R.-Z., Blaileanu G., Hansen B.C., Shuldiner A.R., Gong D.-W.; RT "cDNA cloning, genomic structure, chromosomal mapping, and functional RT expression of a novel human alanine aminotransferase."; RL Genomics 79:445-450(2002). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-22, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [10] RP VARIANTS GLN-430 AND LEU-452. RX PubMed=26477546; DOI=10.1016/j.ajhg.2015.09.009; RG Care4Rare Canada Consortium; RA Srour M., Hamdan F.F., McKnight D., Davis E., Mandel H., RA Schwartzentruber J., Martin B., Patry L., Nassif C., Dionne-Laporte A., RA Ospina L.H., Lemyre E., Massicotte C., Laframboise R., Maranda B., RA Labuda D., Decarie J.C., Rypens F., Goldsher D., Fallet-Bianco C., RA Soucy J.F., Laberge A.M., Maftei C., Boycott K., Brais B., Boucher R.M., RA Rouleau G.A., Katsanis N., Majewski J., Elpeleg O., Kukolich M.K., RA Shalev S., Michaud J.L.; RT "Joubert Syndrome in French Canadians and Identification of Mutations in RT CEP104."; RL Am. J. Hum. Genet. 97:744-753(2015). CC -!- FUNCTION: Catalyzes the reversible transamination between alanine and CC 2-oxoglutarate to form pyruvate and glutamate. Participates in cellular CC nitrogen metabolism and also in liver gluconeogenesis starting with CC precursors transported from skeletal muscles (By similarity). CC {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxoglutarate + L-alanine = L-glutamate + pyruvate; CC Xref=Rhea:RHEA:19453, ChEBI:CHEBI:15361, ChEBI:CHEBI:16810, CC ChEBI:CHEBI:29985, ChEBI:CHEBI:57972; EC=2.6.1.2; CC -!- COFACTOR: CC Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; CC -!- PATHWAY: Amino-acid degradation; L-alanine degradation via transaminase CC pathway; pyruvate from L-alanine: step 1/1. CC -!- SUBUNIT: Homodimer. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- TISSUE SPECIFICITY: Liver, kidney, heart, and skeletal muscles. CC Expressed at moderate levels in the adipose tissue. CC {ECO:0000269|PubMed:11863375}. CC -!- INDUCTION: By glucocorticoids. CC -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent CC aminotransferase family. Alanine aminotransferase subfamily. CC {ECO:0000305}. CC -!- WEB RESOURCE: Name=Wikipedia; Note=Alanine transaminase entry; CC URL="https://en.wikipedia.org/wiki/Alanine_transaminase"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U70732; AAC51155.1; -; Genomic_DNA. DR EMBL; BT006992; AAP35638.1; -; mRNA. DR EMBL; EF444981; ACA05996.1; -; Genomic_DNA. DR EMBL; CH471162; EAW82077.1; -; Genomic_DNA. DR EMBL; CH471162; EAW82078.1; -; Genomic_DNA. DR EMBL; BC018207; AAH18207.1; -; mRNA. DR EMBL; D10355; BAA01186.1; -; mRNA. DR CCDS; CCDS6430.1; -. DR PIR; A40465; A40465. DR RefSeq; NP_005300.1; NM_005309.2. DR RefSeq; XP_011515295.1; XM_011516993.2. DR AlphaFoldDB; P24298; -. DR SMR; P24298; -. DR BioGRID; 109133; 16. DR IntAct; P24298; 3. DR STRING; 9606.ENSP00000378408; -. DR ChEMBL; CHEMBL5929; -. DR DrugBank; DB00160; Alanine. DR DrugBank; DB00142; Glutamic acid. DR DrugBank; DB00780; Phenelzine. DR DrugBank; DB00114; Pyridoxal phosphate. DR iPTMnet; P24298; -. DR PhosphoSitePlus; P24298; -. DR BioMuta; GPT; -. DR DMDM; 46577683; -. DR EPD; P24298; -. DR jPOST; P24298; -. DR MassIVE; P24298; -. DR MaxQB; P24298; -. DR PaxDb; 9606-ENSP00000378408; -. DR PeptideAtlas; P24298; -. DR ProteomicsDB; 54194; -. DR Antibodypedia; 14920; 436 antibodies from 31 providers. DR DNASU; 2875; -. DR Ensembl; ENST00000394955.3; ENSP00000378408.2; ENSG00000167701.14. DR Ensembl; ENST00000528431.5; ENSP00000433586.1; ENSG00000167701.14. DR GeneID; 2875; -. DR KEGG; hsa:2875; -. DR MANE-Select; ENST00000394955.3; ENSP00000378408.2; NM_005309.3; NP_005300.1. DR UCSC; uc003zdh.5; human. DR AGR; HGNC:4552; -. DR CTD; 2875; -. DR DisGeNET; 2875; -. DR GeneCards; GPT; -. DR HGNC; HGNC:4552; GPT. DR HPA; ENSG00000167701; Tissue enhanced (liver). DR MIM; 138200; gene. DR neXtProt; NX_P24298; -. DR OpenTargets; ENSG00000167701; -. DR PharmGKB; PA28947; -. DR VEuPathDB; HostDB:ENSG00000167701; -. DR eggNOG; KOG0258; Eukaryota. DR GeneTree; ENSGT00940000155265; -. DR HOGENOM; CLU_014254_3_1_1; -. DR InParanoid; P24298; -. DR OMA; QVFNKAP; -. DR OrthoDB; 5472891at2759; -. DR PhylomeDB; P24298; -. DR TreeFam; TF300839; -. DR BioCyc; MetaCyc:HS09610-MONOMER; -. DR BRENDA; 2.6.1.2; 2681. DR BRENDA; 2.6.1.4; 2681. DR PathwayCommons; P24298; -. DR Reactome; R-HSA-8964540; Alanine metabolism. DR SignaLink; P24298; -. DR UniPathway; UPA00528; UER00586. DR BioGRID-ORCS; 2875; 12 hits in 1146 CRISPR screens. DR GenomeRNAi; 2875; -. DR Pharos; P24298; Tbio. DR PRO; PR:P24298; -. DR Proteomes; UP000005640; Chromosome 8. DR RNAct; P24298; Protein. DR Bgee; ENSG00000167701; Expressed in right lobe of liver and 110 other cell types or tissues. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0004021; F:L-alanine:2-oxoglutarate aminotransferase activity; IBA:GO_Central. DR GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro. DR GO; GO:0009058; P:biosynthetic process; IEA:InterPro. DR GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl. DR GO; GO:0042853; P:L-alanine catabolic process; IEA:UniProtKB-UniPathway. DR GO; GO:0045722; P:positive regulation of gluconeogenesis; IEA:Ensembl. DR GO; GO:0042594; P:response to starvation; IEA:Ensembl. DR CDD; cd00609; AAT_like; 1. DR Gene3D; 1.10.287.1970; -; 1. DR Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1. DR Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1. DR InterPro; IPR045088; ALAT1/2-like. DR InterPro; IPR004839; Aminotransferase_I/II. DR InterPro; IPR015424; PyrdxlP-dep_Trfase. DR InterPro; IPR015421; PyrdxlP-dep_Trfase_major. DR InterPro; IPR015422; PyrdxlP-dep_Trfase_small. DR PANTHER; PTHR11751; ALANINE AMINOTRANSFERASE; 1. DR PANTHER; PTHR11751:SF308; ALANINE AMINOTRANSFERASE 1; 1. DR Pfam; PF00155; Aminotran_1_2; 1. DR SUPFAM; SSF53383; PLP-dependent transferases; 1. DR Genevisible; P24298; HS. PE 1: Evidence at protein level; KW Acetylation; Aminotransferase; Cytoplasm; Direct protein sequencing; KW Phosphoprotein; Pyridoxal phosphate; Reference proteome; Transferase. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:1931970" FT CHAIN 2..496 FT /note="Alanine aminotransferase 1" FT /id="PRO_0000123933" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000269|PubMed:1931970" FT MOD_RES 22 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:24275569" FT MOD_RES 314 FT /note="N6-(pyridoxal phosphate)lysine" FT /evidence="ECO:0000250" FT VARIANT 14 FT /note="H -> N (in allele GPT*2; dbSNP:rs1063739)" FT /evidence="ECO:0000269|PubMed:9119391, ECO:0000269|Ref.4" FT /id="VAR_000561" FT VARIANT 430 FT /note="E -> Q (found in patient with Joubert syndrome; FT uncertain significance; dbSNP:rs141505249)" FT /evidence="ECO:0000269|PubMed:26477546" FT /id="VAR_075711" FT VARIANT 452 FT /note="V -> L (found in patient with Joubert syndrome; FT uncertain significance; dbSNP:rs147998249)" FT /evidence="ECO:0000269|PubMed:26477546" FT /id="VAR_075712" FT CONFLICT 4..7 FT /note="STGD -> RRGN (in Ref. 7; BAA01186)" FT /evidence="ECO:0000305" FT CONFLICT 39 FT /note="G -> S (in Ref. 7; BAA01186)" FT /evidence="ECO:0000305" FT CONFLICT 222 FT /note="H -> A (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 496 AA; 54637 MW; 23705E7A3A4283B6 CRC64; MASSTGDRSQ AVRHGLRAKV LTLDGMNPRV RRVEYAVRGP IVQRALELEQ ELRQGVKKPF TEVIRANIGD AQAMGQRPIT FLRQVLALCV NPDLLSSPNF PDDAKKRAER ILQACGGHSL GAYSVSSGIQ LIREDVARYI ERRDGGIPAD PNNVFLSTGA SDAIVTVLKL LVAGEGHTRT GVLIPIPQYP LYSATLAELG AVQVDYYLDE ERAWALDVAE LHRALGQARD HCRPRALCVI NPGNPTGQVQ TRECIEAVIR FAFEERLFLL ADEVYQDNVY AAGSQFHSFK KVLMEMGPPY AGQQELASFH STSKGYMGEC GFRGGYVEVV NMDAAVQQQM LKLMSVRLCP PVPGQALLDL VVSPPAPTDP SFAQFQAEKQ AVLAELAAKA KLTEQVFNEA PGISCNPVQG AMYSFPRVQL PPRAVERAQE LGLAPDMFFC LRLLEETGIC VVPGSGFGQR EGTYHFRMTI LPPLEKLRLL LEKLSRFHAK FTLEYS //